These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 27915071)

  • 21. Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra.
    Knyihár-Csillik E; Chadaide Z; Mihály A; Krisztin-Péva B; Fenyo R; Vécsei L
    Acta Neuropathol; 2006 Aug; 112(2):127-37. PubMed ID: 16788821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease.
    Zecca L; Wilms H; Geick S; Claasen JH; Brandenburg LO; Holzknecht C; Panizza ML; Zucca FA; Deuschl G; Sievers J; Lucius R
    Acta Neuropathol; 2008 Jul; 116(1):47-55. PubMed ID: 18343932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen modulation of calretinin and BDNF expression in midbrain dopaminergic neurons of ovariectomised mice.
    Yi H; Bao X; Tang X; Fan X; Xu H
    J Chem Neuroanat; 2016 Nov; 77():60-67. PubMed ID: 27211874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoro-Jade C can specifically stain the degenerative neurons in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine-treated C57BL/6 mice.
    Bian GL; Wei LC; Shi M; Wang YQ; Cao R; Chen LW
    Brain Res; 2007 May; 1150():55-61. PubMed ID: 17397812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain.
    Beck KD; Valverde J; Alexi T; Poulsen K; Moffat B; Vandlen RA; Rosenthal A; Hefti F
    Nature; 1995 Jan; 373(6512):339-41. PubMed ID: 7830767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area.
    Krashia P; Martini A; Nobili A; Aversa D; D'Amelio M; Berretta N; Guatteo E; Mercuri NB
    Eur J Neurosci; 2017 Jan; 45(1):92-105. PubMed ID: 27519559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and functional properties of TRPM2 channels in dopaminergic neurons of the substantia nigra of the rat.
    Chung KK; Freestone PS; Lipski J
    J Neurophysiol; 2011 Dec; 106(6):2865-75. PubMed ID: 21900507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the sonic hedgehog receptor smoothened on the survival and function of dopaminergic neurons.
    Zhou X; Pace J; Filichia E; Lv T; Davis B; Hoffer B; Selman W; Luo Y
    Exp Neurol; 2016 Sep; 283(Pt A):235-45. PubMed ID: 27317298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
    Li J; Wang LN; Xiao HL; Li X; Yang JJ
    Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
    Suzuki S; Kawamata J; Iwahara N; Matsumura A; Hisahara S; Matsushita T; Sasaki M; Honmou O; Shimohama S
    Neurosci Lett; 2015 Jan; 584():276-81. PubMed ID: 25449872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphfunctional interaction of cart-peptide and dopaminergic brain neurons].
    Romanova IV
    Zh Evol Biokhim Fiziol; 2013; 49(1):78-84. PubMed ID: 23662485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of prothrombin kringle-2-induced inflammation by minocycline protects dopaminergic neurons in the substantia nigra in vivo.
    Nam JH; Leem E; Jeon MT; Kim YJ; Jung UJ; Choi MS; Maeng S; Jin BK; Kim SR
    Neuroreport; 2014 May; 25(7):489-95. PubMed ID: 24488033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predominant surface distribution of neurokinin-3 receptors in non-dopaminergic dendrites in the rat substantia nigra and ventral tegmental area.
    Lessard A; Grady EF; Bunnett NW; Pickel VM
    Neuroscience; 2007 Feb; 144(4):1393-408. PubMed ID: 17197098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild hyperbaric oxygen inhibits the decrease of dopaminergic neurons in the substantia nigra of mice with MPTP-induced Parkinson's disease.
    Kusuda Y; Takemura A; Nakano M; Ishihara A
    Neurosci Res; 2018 Jul; 132():58-62. PubMed ID: 29196223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switching the microglial harmful phenotype promotes lifelong restoration of subtantia nigra dopaminergic neurons from inflammatory neurodegeneration in aged mice.
    L'episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Impagnatiello F; Marchetti B
    Rejuvenation Res; 2011 Aug; 14(4):411-24. PubMed ID: 21793734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic neuron loss and up-regulation of chaperone protein mRNA induced by targeted over-expression of alpha-synuclein in mouse substantia nigra.
    St Martin JL; Klucken J; Outeiro TF; Nguyen P; Keller-McGandy C; Cantuti-Castelvetri I; Grammatopoulos TN; Standaert DG; Hyman BT; McLean PJ
    J Neurochem; 2007 Mar; 100(6):1449-57. PubMed ID: 17241127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys.
    Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR
    J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.